Tag Archives: Howard Mayer M.D.

Shire to present new data on recombinant human parathyroid hormone and on the management of chronic hypoparathyroidism at the Endocrine Society’s 100th Annual Meeting and Exposition

Posted on 13, March 2018 by

Clinical and real-world insights on recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and the management of chronic hypoparathyroidism to be presented Hypoparathyroidism is a rare endocrine disease that can have a significant impact on patients New data highlight Shire’s commitment to … Read the full press release →

Posted in Healthcare, Ireland, Pharma & Biotech

Tagged , , , , , , , ,

Shire CMO Howard Mayer, M.D.: no patient is currently being denied access to treatment with Hemlibra

Posted on 16, January 2018 by

DUBLIN, 16-Jan-2018 — /EuropaWire/ — At Shire, we’ve been committed to the hemophilia community and the lives of every patient afflicted with this disease for more than 70 years. We are very proud of this legacy and take our role as … Read the full press release →

Posted in Healthcare, Ireland, Pharma & Biotech

Tagged , , , , , , , , ,

Shire submits MAA for lifitegrast: If approved it will address the signs and symptoms of dry eye disease in adults in Europe

Posted on 16, August 2017 by

Lifitegrast, if approved, would be the first and only new class treatment to address the signs and symptoms of dry eye disease in adults in Europe ZUG, 16-Aug-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the Marketing Authorization … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,